Literature DB >> 22257011

Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'.

Tom P Freeman1, Celia J A Morgan, James Vaughn-Jones, Nahida Hussain, Kash Karimi, H Valerie Curran.   

Abstract

AIMS: Use of the stimulant drug mephedrone increased dramatically in 2009, and it is still available in the United Kingdom after being controlled in April 2010. This study aimed to assess mephedrone's acute cognitive and subjective effects.
DESIGN: A mixed within- and between-subjects design compared 20 mephedrone users, first while intoxicated (T1) and secondly drug free (T2); and 20 controls twice when drug free (T1 and T2). SETTINGS: Participants' own homes. PARTICIPANTS: Healthy adults recruited from the community. MEASUREMENTS: Subjective effects, episodic and working memory, phonological and semantic fluency, psychomotor speed and executive control at were assessed at T1 and T2. Trait schizotypy, depression, changes in mephedrone use since the ban and attitudes influencing use of a hypothetical new legal high were indexed at T2 only.
FINDINGS: Compared with controls, mephedrone users had generally impaired prose recall (P = 0.037) and higher scores in schizotypy (P < 0.001) and depression (P = 0.01). Mephedrone acutely primed a marked 'wanting' for the drug (P < 0.001), induced stimulant-like effects, impaired working memory (P < 0.001) and enhanced psychomotor speed (P = 0.024). Impulsivity in mephedrone users correlated with the number of hours in an average (nearly 8 hour) mephedrone session (r = 0.6). Users would be drawn to use a new legal high if it were pure, had no long/short term harms, and was positively rated by friends or on the internet.
CONCLUSIONS: Mephedrone impairs working memory acutely, induces stimulant-like effects in users and is associated with binge use. Factors that influence users' attitudes to new drugs might help to predict future trends in use of the many new psychoactive substances emerging on the internet.
© 2012 The Authors, Addiction © 2012 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257011     DOI: 10.1111/j.1360-0443.2011.03719.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  31 in total

1.  Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine.

Authors:  J Elliott Robinson; Abigail E Agoglia; Eric W Fish; Michael C Krouse; C J Malanga
Journal:  Behav Brain Res       Date:  2012-06-21       Impact factor: 3.332

2.  Mephedrone alters basal ganglia and limbic dynorphin systems.

Authors:  Christopher L German; Mario E Alburges; Amanda J Hoonakker; Annette E Fleckenstein; Glen R Hanson
Journal:  Synapse       Date:  2014-09-08       Impact factor: 2.562

Review 3.  Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

Authors:  Christopher L German; Annette E Fleckenstein; Glen R Hanson
Journal:  Life Sci       Date:  2013-08-02       Impact factor: 5.037

Review 4.  The assessment of schizotypy and its clinical relevance.

Authors:  Oliver J Mason
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

5.  Synthetic cathinones and their rewarding and reinforcing effects in rodents.

Authors:  Lucas R Watterson; M Foster Olive
Journal:  Adv Neurosci (Hindawi)       Date:  2014-06-04

6.  The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland.

Authors:  Pirkko Kriikku; Janne Rintatalo; Katja Pihlainen; Jukka Hurme; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2015-04-02       Impact factor: 2.686

7.  Mephedrone (4-methylmethcathinone) and d-methamphetamine improve visuospatial associative memory, but not spatial working memory, in rhesus macaques.

Authors:  M J Wright; S A Vandewater; D Angrish; T J Dickerson; M A Taffe
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

8.  Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Kaveish Sewalia; Lucas R Watterson; Alyssa Hryciw; Anna Belloc; J Bryce Ortiz; M Foster Olive
Journal:  Neuropharmacology       Date:  2017-11-26       Impact factor: 5.250

9.  Association of Schizotypy With Dimensions of Cognitive Control: A Meta-Analysis.

Authors:  Maria Steffens; Inga Meyhöfer; Kaja Fassbender; Ulrich Ettinger; Joseph Kambeitz
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

10.  Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone.

Authors:  Gavin McLaughlin; Noreen Morris; Pierce V Kavanagh; John D Power; Geraldine Dowling; Brendan Twamley; John O'Brien; Brian Talbot; Donna Walther; John S Partilla; Michael H Baumann; Simon D Brandt
Journal:  Drug Test Anal       Date:  2016-09-21       Impact factor: 3.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.